Johnson & Johnson
JNJ
#21
Rank
NZ$941.37 B
Marketcap
NZ$390.63
Share price
-1.49%
Change (1 day)
51.75%
Change (1 year)

Johnson & Johnson is a global American pharmaceutical and consumer goods company with headquarters in New Brunswick, New Jersey. The company is listed in the Dow Jones Industrial Average.

EPS for Johnson & Johnson (JNJ)

EPS in 2025 (TTM): NZ$19.20

According to Johnson & Johnson's latest financial reports the company's current EPS (TTM) is NZ$18.86. an increase over its 2024 EPS that were of NZ$11.33.

EPS history for Johnson & Johnson from 2012 to 2025

Annual EPS

Year EPS Change
2025NZ$18.7165.13%
2024NZ$11.33-53.6%
2023NZ$24.42111.16%
2022NZ$11.56-13.84%
2021NZ$13.4241.81%
2020NZ$9.47-18.92%
2019NZ$11.6721.2%
2018NZ$9.631125.3%
2017NZ$0.79-92.23%
2016NZ$10.117.37%
2015NZ$9.42-4.16%
2014NZ$9.8318.1%
2013NZ$8.3224.88%
2012NZ$6.66

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
NZ$12.19-35.36%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.30-87.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$6.35-66.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
NZ$6.08-67.77%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
NZ$38.99 106.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$3.50-81.46%๐Ÿ‡ซ๐Ÿ‡ท France
Gilead Sciences
GILD
NZ$11.60-38.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Stryker Corporation
SYK
NZ$14.38-23.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.38-34.37%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$6.38-66.17%๐Ÿ‡ฌ๐Ÿ‡ง UK